However, from Figures 7D,E, we found that only the survival rate of TRIP13 in the high expression group was significantly lower than that of the low expression group, while the survival rate of the ACAD11 high expression group was higher than that of the low expression group, indicating that TRIP13 has a significant function in ccRCC and can serve as an independent prognostic gene in the disease. This evidence concerns the gene ACAD11 and nonpapillary renal cell carcinoma.